Skip to main content
LYKALABS · Health Care · 2026-08-07

Lyka Labs Ltd

Stage 1 · wk 10In scan: Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹66.7
-2.00% today
₹241 Cr · Micro cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.

Visit company website →
vs 52W High
-42.6%
₹45 lo₹116.2 hi
42.6% below 52W high
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 10
1w13w26w
Week 10 — base building
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
-4.8%
200 DMA: ₹70.1 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.12x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
MA20 rolling over · -5.4% vs MA50 +3.0%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
Sector has 79 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
→ Flat
Stage 2%
50.5%
20d Δ
+0.5pp
1M return
+1.9%
3M return
+11.7%
Industry Stage-2 % · last 20 days
Industry has 53 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-12 → 2026-08-07
S2 16w
S4 43w
2023-05-122026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 6w → S1 13w → S4 1w → S1 2w → S2 4w → S3 2w → S2 16w → S3 8w → S4 13w → S1 3w → S2 12w → S3 2w → S2 9w → S3 4w → S4 11w → S1 10w → S4 43w → S1 9w current
Total tracked: 167 weeks across 18 stage runs.
1M
-2.7%
3M
+2.1%
6M
-5.8%
YTD
-10.8%
1Y
-42.1%
Scan Membership
Breakout Watch
Latest: 2024-12-12
2 appearances in last 60 days. First seen: 2024-08-30.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S1
Wk 10 · Vol x
2026-08-06S1
Wk 9 · Vol x
2026-08-05S1
Wk 9 · Vol x
2026-08-04S1
Wk 9 · Vol x
2026-08-03S1
Wk 9 · Vol x
2026-07-31S1
Wk 9 · Vol x
2026-07-30S1
Wk 8 · Vol x
2026-07-29S1
Wk 8 · Vol x
2026-07-28S1
Wk 8 · Vol x
2026-07-27S1
Wk 8 · Vol x
2026-07-24S1
Wk 8 · Vol x
2026-07-23S1
Wk 7 · Vol x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹67.1
200 DMA
₹70.1
52W High
₹116.2
52W Low
₹45
5D Low
₹63.8
Resistance levels (recent highs)
20d High
₹70.1
60d High
₹74.8
120d High
₹74.8
250d High
₹110.7
Next resistance
+5.1%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.